Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06810427 · ClinicalTrials.gov registry record · NA
A Novel, Low-Cost, Handheld 3D Imaging System for Improved Screening for Cervical Neoplasia in Resource-Limited Settings
A NA study of Cervical Intraepithelial Neoplasia, sponsored by Carilion Clinic.
- Active
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT06810427: Active NA study of Cervical Intraepithelial Neoplasia, sponsored by Carilion Clinic.
NCT06810427 is a NA study of Cervical Intraepithelial Neoplasia that is active but no longer recruiting, run by Carilion Clinic. The registered enrollment target is 18 participants, below the 268-participant average among 6 other Cervical Intraepithelial Neoplasia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06810427, a NA study of Cervical Intraepithelial Neoplasia, is active but no longer recruiting, sponsored by Carilion Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the design and engineering of a new minimally invasive medical imaging device (CervImage™). Investigators are trying to find out if CervImage™ is reliable and easy to use to obtain clinical 3D photographs and to record 3D measurements in human cervixes. Investigators then plan to use these images to determine if CervImage™ design and engineering improvements need to be made.
Primary Outcome
CervImage images evaluated on Spatial resolution, distortion, brightness, magnification, color correctness, corrupted pixel rows, and visual inspection vs standard-of-care cervical imaging for intraepithelial dysplasia \[CIN\] visualization.
Conditions Studied
Interventions
- DEVICE CervImage device
Study Locations (1)
Virginia
- Carilion Clinic - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2025-01-16 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What the registry record for NCT06810427 still lists
NCT06810427 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 268-participant average among 6 other Cervical Intraepithelial Neoplasia trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Cervical Intraepithelial Neoplasia appearing as the primary indexed condition, and to 1 intervention - of which CervImage device is the first listed.
NCT06810427 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06810427 about?
NCT06810427 is a clinical study titled "A Novel, Low-Cost, Handheld 3D Imaging System for Improved Screening for Cervical Neoplasia in Resource-Limited Settings". The purpose of this study is to evaluate the design and engineering of a new minimally invasive medical imaging device (CervImage™). Investigators are trying to find out if CervImage™ is reliable and easy to use to obtain clinical 3D photographs and to record 3D measurements in human cervixes. Inves...
What is the current status of trial NCT06810427?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2025-01-16. Estimated completion is 2026-07-31.
What conditions does trial NCT06810427 study?
This clinical trial studies the following conditions: Cervical Intraepithelial Neoplasia.
What interventions are being tested in trial NCT06810427?
The interventions under investigation include: CervImage device (DEVICE).
Who is sponsoring clinical trial NCT06810427?
This trial is sponsored by Carilion Clinic, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06810427 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Intraepithelial Neoplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia
RECRUITING · Phase 2
-
Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma
RECRUITING · Phase 1
-
Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV
RECRUITING · Phase 4
-
Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
COMPLETED · Phase 2
-
A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age
COMPLETED · Phase 1
-
A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI